These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9180827)

  • 21. Buspirone and imipramine for the treatment of major depression in the elderly.
    Schweizer E; Rickels K; Hassman H; Garcia-España F
    J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapies for cannabis dependence.
    Nielsen S; Gowing L; Sabioni P; Le Foll B
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD008940. PubMed ID: 30687936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.
    Sabuncuoglu O; Ekinci O; Berkem M
    Spec Care Dentist; 2009; 29(5):215-7. PubMed ID: 19740153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases.
    Thomsen PH; Mikkelsen HU
    Eur Child Adolesc Psychiatry; 1999 Jun; 8(2):143-8. PubMed ID: 10435463
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of antidepressant nonresponders: augmentation or switch?
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 15():35-41. PubMed ID: 9786309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
    Landén M; Högberg P; Thase ME
    J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
    Abbas S; Chandra PS; Srivastava M
    J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
    Spigset O; Adielsson G
    Int Clin Psychopharmacol; 1997 Jan; 12(1):61-3. PubMed ID: 9179637
    [No Abstract]   [Full Text] [Related]  

  • 31. 'The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia'--1997, 12, 519-527.
    Lawlor B
    Int J Geriatr Psychiatry; 1998 Jul; 13(7):496. PubMed ID: 9695043
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM
    J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.
    Papakostas GI; Chuzi SE; Sousa JL; Fava M
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):175-80. PubMed ID: 19641981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression.
    Robinson DS; Rickels K; Feighner J; Fabre LF; Gammans RE; Shrotriya RC; Alms DR; Andary JJ; Messina ME
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):67S-76S. PubMed ID: 2198303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buspirone as an antidote to SSRI-induced bruxism in 4 cases.
    Bostwick JM; Jaffee MS
    J Clin Psychiatry; 1999 Dec; 60(12):857-60. PubMed ID: 10665633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia.
    Van Ameringen M; Mancini C; Wilson C
    J Affect Disord; 1996 Jul; 39(2):115-21. PubMed ID: 8827420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of papaverine addition for treatment-refractory major depression.
    Malison RT; Price LH; Nestler EJ; Heninger GR; Duman RS
    Am J Psychiatry; 1997 Apr; 154(4):579-80. PubMed ID: 9090353
    [No Abstract]   [Full Text] [Related]  

  • 38. Augmentation strategies to increase antidepressant efficacy.
    Shelton RC
    J Clin Psychiatry; 2007; 68 Suppl 10():18-22. PubMed ID: 17900205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.
    Michelson D; Bancroft J; Targum S; Kim Y; Tepner R
    Am J Psychiatry; 2000 Feb; 157(2):239-43. PubMed ID: 10671393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.